| تعداد نشریات | 282 |
| تعداد نشریات سازمان | 80 |
| تعداد شماره‌ها | 3,272 |
| تعداد مقالات | 36,131 |
| تعداد مشاهده مقاله | 55,698,232 |
| تعداد دریافت فایل اصل مقاله | 94,483,301 |
Microneedle-based Rabies Vaccination: A Promising Approach Toward the WHO “Zero by 30” Target | ||
| Archives of Razi Institute | ||
| مقاله 22، دوره 81، شماره 1، فروردین و اردیبهشت 2026، صفحه 191-202 اصل مقاله (2.87 M) | ||
| نوع مقاله: Original Articles | ||
| شناسه دیجیتال (DOI): 10.66224/ARI.81.1.3942 | ||
| نویسندگان | ||
| Mehrnaz Hosseini Tehrani1؛ Reza Aramideh Khouy1؛ Atefeh Malek-Khatabi2؛ Mazda Rad-Malekshahi3؛ Atefeh Kachooei1؛ Maryam Shahali4؛ Babak Peirovi5؛ Leila Mousavizadeh1؛ Hossein Keyvani* 1؛ Angila Ataei‐Pirkooh* 1 | ||
| 1Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. | ||
| 2Center for Advanced Biomaterials for Health Care (CABHC), Italian Institute of Technology, Napoli, Italy. | ||
| 3Department of Pharmaceutical Biomaterials, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. | ||
| 4Department of Viral Vaccines Production, Research and Production Complex, Pasteur Institute of Iran, Tehran, Iran. | ||
| 5Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. | ||
| چکیده | ||
| Introduction: Rabies remains a fatal zoonotic disease causing tens of thousands of deaths annually, predominantly in resource-limited countries, where intramuscular (IM) vaccines are limited by cost, cold-chain needs, and the need for skilled administration. Achieving the World Health Organization’s “Zero by 30” target necessitates innovative, scalable, and cost-effective vaccine delivery approaches. In this study, we developed dissolving microneedle (MN) patches (dMNPs) loaded with rabies vaccine using hyaluronic acid (HA) and polyvinylpyrrolidone (PVP) as biocompatible and biodegradable polymers. Materials & Methods: An aluminum master mold fabricated by CNC machining contained 400 cubical-pyramidal MNs (800 µm height, 300×300 µm base), while PDMS replicas enabled precise two-step centrifugal casting. Morphology, virion integrity, mechanical strength, and ex vivo skin penetration were evaluated. Bagg Albino/subline C (BALB/c) mice received two doses of vaccine-loaded microneedles, IM injection, or blank patches, and virus-neutralizing antibodies were measured. Results: MNs exhibited uniform geometry (651.2±4.3 μm height), high mechanical strength (0.403±0.006 N/needle), and reliable skin penetration (~300 μm). Transmission electron microscopy confirmed that rabies virions retained their bullet-shaped morphology after encapsulation and storage. Rabies virus-neutralizing antibodies showed comparable titers four weeks post-booster: dMNP (1 mg; geometric mean titers (GMTs): 7.67 IU/mL, 95% CI, 6.8%, 8.64%) versus IM (10 mg; GMT: 6.95 IU/mL, 95% CI, 6.2%, 7.8%; P>0.05), both surpassing protective thresholds (≥0.5 IU/mL), while controls remained seronegative. Conclusion: Beyond achieving robust immune responses, these dMNPs provide dose-sparing, thermostability, self-administration, and sharps-free delivery—which enhance feasibility, acceptance, and scalability, aligning with the WHO’s “Zero by 30” target. This platform offers translational potential for equitable rabies prophylaxis in resource-limited settings. | ||
| کلیدواژه‌ها | ||
| Microneedle؛ Post-exposure prophylaxis (PEP)؛ Rabies؛ Rabies vaccine؛ Vaccination | ||
| عنوان مقاله [English] | ||
| واکسیناسیون هاری مبتنی بر ریزسوزن: رویکردی امیدبخش در راستای هدف "صفر مورد تا سال ۲۰۳۰" سازمان جهانی بهداشت | ||
|
سایر فایل های مرتبط با مقاله
|
||
| مراجع | ||
|
Walker PJ, Freitas-Astúa J, Bejerman N, Blasdell KR, Breyta R, Dietzgen RG, et al. ICTV Virus taxonomy profile: Rhabdoviridae 2022. J Gen Virol. 2022; 103(6). [DOI:10.1099/jgv.0.001689][PMID]
World Health O. Rabies vaccines: WHO position paper, April 2018 - recommendations. Vaccine. 2018; 36(37):5500-3. [DOI:10.1016/j.vaccine.2018.06.061] [PMID]
Abela-Ridder B, Knopf L, Martin S, Taylor L, Torres G, De Balogh K. 2016: The beginning of the end of rabies? Lancet Glob Health. 2016; 4(11):e780-e1. [DOI:10.1016/S2214-109X(16)30245-5] [PMID]
Vescovo P, Rettby N, Ramaniraka N, Liberman J, Hart K, Cachemaille A, et al. Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™. Vaccine. 2017; 35(14):1782-8. [DOI:10.1016/j.vaccine.2016.09.069] [PMID]
Kerdpanich P, Chanthavanich P, De Los Reyes MR, Lim J, Yu D, Ama MC, et al. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. PLoS Negl Trop Dis. 2018; 12(6):e0006340. [DOI:10.1371/journal.pntd.0006340][PMID]
Limenh LW. Advances in the transdermal delivery of antiretroviral drugs. SAGE Open Med. 2024; 12:20503121231223600. [DOI:10.1177/20503121231223600] [PMID]
O’Shea J, Prausnitz MR, Rouphael N. Dissolvable microneedle patches to enable increased access to vaccines against SARS-CoV-2 and future pandemic outbreaks. Vaccines (Basel). 2021; 9(4):320. [DOI:10.3390/vaccines9040320][PMID]
Kuwentrai C, Yu J, Zhang BZ, Hu YF, Dou Y, Gong HR, et al. Induction of humoral and cellular immunity by intradermal delivery of SARS-CoV-2 nucleocapsid protein using dissolvable microneedles. J Immunol Res. 2021; 2021:5531220. [DOI:10.1155/2021/5531220][PMID]
Garg N, Tellier G, Vale N, Kluge J, Portman JL, Markowska A, et al. Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults. Plos One. 2024; 19(6):e0303450. [DOI:10.1371/journal.pone.0303450][PMID]
Moon SS, Richter-Roche M, Resch TK, Wang Y, Foytich KR, Wang H, et al. Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine. NPJ Vaccines. 2022; 7(1):26. [DOI:10.1038/s41541-022-00443-7][PMID]
Malek-Khatabi A, Faraji Rad Z, Rad-Malekshahi M, Akbarijavar H. Development of dissolvable microneedle patches by CNC machining and micromolding for drug delivery. Mater Lett. 2023; 330:133328. [DOI:10.1016/j.matlet.2022.133328]
Yager ML, Moore SM. The rapid fluorescent focus inhibition test, In: Rupprecht C, Nagarajan T, editors. Current laboratory techniques in rabies diagnosis. Research and Prevention. Academic Press; 2015.
Malek-Khatabi A, Rad-Malekshahi M, Shafiei M, Sharifi F, Motasadizadeh H, Ebrahiminejad V, et al. Botulinum toxin A dissolving microneedles for hyperhidrosis treatment: design, formulation and in vivo evaluation. Biomater Sci. 2023; 11(24):7784-804. [DOI:10.1039/D3BM01301D] [PMID]
Zhao X, Li X, Zhang P, Du J, Wang Y. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor. J Control Release. 2018; 286:201-9. [DOI:10.1016/j.jconrel.2018.07.038] [PMID]
Champeau M, Jary D, Mortier L, Mordon S, Vignoud S. A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid. Int J Pharm. 2020; 586:119554. [DOI:10.1016/j.ijpharm.2020.119554] [PMID]
Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004; 37(8):1155-63. [DOI:10.1016/j.jbiomech.2003.12.010][PMID]
Kim YC, Lee JW, Esser ES, Kalluri H, Joyce JC, Compans RW, et al. Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent. Drug Deliv Transl Res. 2021; 11(2):692-701. [DOI:10.1007/s13346-021-00927-4] [PMID]
Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010; 16(8):915-20. [DOI:10.1038/nm.2182][PMID]
Navarro Sanchez ME, Soulet D, Bonnet E, Guinchard F, Marco S, Vetter E, et al. Rabies vaccine characterization by nanoparticle tracking analysis. Sci Rep. 2020; 10(1):8149. [DOI:10.1038/s41598-020-64572-6][PMID]
Chu LY, Ye L, Dong K, Compans RW, Yang C, Prausnitz MR. Enhanced stability of inactivated influenza vaccine encapsulated in dissolving microneedle patches. Pharm Res. 2016; 33(4):868-78. [DOI:10.1007/s11095-015-1833-9] [PMID]
Arya JM, Dewitt K, Scott-Garrard M, Chiang YW, Prausnitz MR. Rabies vaccination in dogs using a dissolving microneedle patch. J Control Release. 2016; 239:19-26. [DOI:10.1016/j.jconrel.2016.08.012] [PMID]
Arshad MS, Nazari K, Rana SJ, Zafar S, Uzair M, Ahmad Z. Dissolving microneedle patches as vaccine delivery platforms. Br J Pharm. 2023; 8(2). [DOI:10.5920/bjpharm.1334]
Arshad MS, Hussain S, Zafar S, Rana SJ, Ahmad N, Jalil NA, et al. Improved transdermal delivery of rabies vaccine using iontophoresis coupled microneedle approach. Pharm Res. 2023; 40(8):2039-49. [DOI:10.1007/s11095-023-03521-0] [PMID] | ||
|
آمار تعداد مشاهده مقاله: 357 تعداد دریافت فایل اصل مقاله: 482 |
||
